nodes	percent_of_prediction	percent_of_DWPC	metapath
Calcitriol—CYP3A4—Cytarabine—lymphatic system cancer	0.0785	0.318	CbGbCtD
Calcitriol—CYP3A4—Teniposide—lymphatic system cancer	0.0773	0.313	CbGbCtD
Calcitriol—CYP3A4—Mitoxantrone—lymphatic system cancer	0.054	0.219	CbGbCtD
Calcitriol—CYP3A4—Vincristine—lymphatic system cancer	0.0372	0.151	CbGbCtD
Calcitriol—Hyperphosphataemia—Fludarabine—lymphatic system cancer	0.0311	0.0414	CcSEcCtD
Calcitriol—Blister—Mechlorethamine—lymphatic system cancer	0.0228	0.0303	CcSEcCtD
Calcitriol—Hyperphosphataemia—Mitoxantrone—lymphatic system cancer	0.0185	0.0246	CcSEcCtD
Calcitriol—Stomach ache—Mitoxantrone—lymphatic system cancer	0.0149	0.0198	CcSEcCtD
Calcitriol—Dermatitis bullous—Mechlorethamine—lymphatic system cancer	0.0125	0.0166	CcSEcCtD
Calcitriol—Urine abnormality—Mitoxantrone—lymphatic system cancer	0.0114	0.0152	CcSEcCtD
Calcitriol—Urine analysis abnormal—Mitoxantrone—lymphatic system cancer	0.0108	0.0143	CcSEcCtD
Calcitriol—Serum creatinine increased—Mitoxantrone—lymphatic system cancer	0.0103	0.0137	CcSEcCtD
Calcitriol—Taste metallic—Methotrexate—lymphatic system cancer	0.00992	0.0132	CcSEcCtD
Calcitriol—Abdominal cramps—Vincristine—lymphatic system cancer	0.00963	0.0128	CcSEcCtD
Calcitriol—Haemoglobin—Mechlorethamine—lymphatic system cancer	0.00829	0.011	CcSEcCtD
Calcitriol—Haemorrhage—Mechlorethamine—lymphatic system cancer	0.00825	0.011	CcSEcCtD
Calcitriol—Erythema multiforme—Mechlorethamine—lymphatic system cancer	0.0078	0.0104	CcSEcCtD
Calcitriol—Dehydration—Fludarabine—lymphatic system cancer	0.00718	0.00954	CcSEcCtD
Calcitriol—Bone pain—Vincristine—lymphatic system cancer	0.00679	0.00901	CcSEcCtD
Calcitriol—Bone pain—Mitoxantrone—lymphatic system cancer	0.00661	0.00878	CcSEcCtD
Calcitriol—Haemoglobin—Teniposide—lymphatic system cancer	0.00611	0.00812	CcSEcCtD
Calcitriol—Haemorrhage—Teniposide—lymphatic system cancer	0.00608	0.00808	CcSEcCtD
Calcitriol—Blood urea increased—Mitoxantrone—lymphatic system cancer	0.00598	0.00794	CcSEcCtD
Calcitriol—Urine output increased—Vincristine—lymphatic system cancer	0.00588	0.00781	CcSEcCtD
Calcitriol—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.00586	0.00778	CcSEcCtD
Calcitriol—Urinary tract infection—Fludarabine—lymphatic system cancer	0.00579	0.00768	CcSEcCtD
Calcitriol—Skin disorder—Mechlorethamine—lymphatic system cancer	0.00569	0.00756	CcSEcCtD
Calcitriol—Anorexia—Mechlorethamine—lymphatic system cancer	0.00559	0.00742	CcSEcCtD
Calcitriol—Arrhythmia—Teniposide—lymphatic system cancer	0.00543	0.00721	CcSEcCtD
Calcitriol—Polyuria—Vincristine—lymphatic system cancer	0.00537	0.00714	CcSEcCtD
Calcitriol—Haemoglobin—Fludarabine—lymphatic system cancer	0.00537	0.00713	CcSEcCtD
Calcitriol—Haemorrhage—Fludarabine—lymphatic system cancer	0.00534	0.0071	CcSEcCtD
Calcitriol—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00509	0.00677	CcSEcCtD
Calcitriol—Erythema multiforme—Fludarabine—lymphatic system cancer	0.00505	0.00671	CcSEcCtD
Calcitriol—Psoriasis—Methotrexate—lymphatic system cancer	0.00502	0.00667	CcSEcCtD
Calcitriol—Agitation—Teniposide—lymphatic system cancer	0.00486	0.00646	CcSEcCtD
Calcitriol—Arrhythmia—Fludarabine—lymphatic system cancer	0.00477	0.00634	CcSEcCtD
Calcitriol—Pain in extremity—Vincristine—lymphatic system cancer	0.00472	0.00627	CcSEcCtD
Calcitriol—Hypertension—Teniposide—lymphatic system cancer	0.00457	0.00607	CcSEcCtD
Calcitriol—Chest pain—Teniposide—lymphatic system cancer	0.00451	0.00598	CcSEcCtD
Calcitriol—Weight decreased—Bleomycin—lymphatic system cancer	0.00443	0.00588	CcSEcCtD
Calcitriol—Dehydration—Vincristine—lymphatic system cancer	0.00439	0.00583	CcSEcCtD
Calcitriol—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00432	0.00573	CcSEcCtD
Calcitriol—Blood creatinine increased—Mitoxantrone—lymphatic system cancer	0.00431	0.00572	CcSEcCtD
Calcitriol—Agitation—Fludarabine—lymphatic system cancer	0.00428	0.00568	CcSEcCtD
Calcitriol—Dehydration—Mitoxantrone—lymphatic system cancer	0.00427	0.00568	CcSEcCtD
Calcitriol—Aspartate aminotransferase increased—Vincristine—lymphatic system cancer	0.00425	0.00564	CcSEcCtD
Calcitriol—Abdominal pain upper—Mitoxantrone—lymphatic system cancer	0.0042	0.00558	CcSEcCtD
Calcitriol—Pruritus—Mechlorethamine—lymphatic system cancer	0.00415	0.00551	CcSEcCtD
Calcitriol—Aspartate aminotransferase increased—Mitoxantrone—lymphatic system cancer	0.00414	0.0055	CcSEcCtD
Calcitriol—Anorexia—Teniposide—lymphatic system cancer	0.00412	0.00547	CcSEcCtD
Calcitriol—Convulsion—Fludarabine—lymphatic system cancer	0.00403	0.00535	CcSEcCtD
Calcitriol—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00401	0.00532	CcSEcCtD
Calcitriol—Myalgia—Fludarabine—lymphatic system cancer	0.00396	0.00526	CcSEcCtD
Calcitriol—Haemoglobin—Bleomycin—lymphatic system cancer	0.00394	0.00523	CcSEcCtD
Calcitriol—Haemorrhage—Bleomycin—lymphatic system cancer	0.00392	0.0052	CcSEcCtD
Calcitriol—Discomfort—Fludarabine—lymphatic system cancer	0.00391	0.0052	CcSEcCtD
Calcitriol—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.0038	0.00504	CcSEcCtD
Calcitriol—Decreased appetite—Teniposide—lymphatic system cancer	0.00376	0.00499	CcSEcCtD
Calcitriol—Vomiting—Mechlorethamine—lymphatic system cancer	0.00373	0.00495	CcSEcCtD
Calcitriol—Urinary tract infection—Carmustine—lymphatic system cancer	0.0037	0.00492	CcSEcCtD
Calcitriol—Rash—Mechlorethamine—lymphatic system cancer	0.00369	0.00491	CcSEcCtD
Calcitriol—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00369	0.0049	CcSEcCtD
Calcitriol—Weight decreased—Vincristine—lymphatic system cancer	0.00369	0.0049	CcSEcCtD
Calcitriol—Anorexia—Fludarabine—lymphatic system cancer	0.00362	0.00481	CcSEcCtD
Calcitriol—Weight decreased—Mitoxantrone—lymphatic system cancer	0.00359	0.00477	CcSEcCtD
Calcitriol—Drowsiness—Mitoxantrone—lymphatic system cancer	0.00354	0.0047	CcSEcCtD
Calcitriol—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00353	0.00469	CcSEcCtD
Calcitriol—Nausea—Mechlorethamine—lymphatic system cancer	0.00348	0.00462	CcSEcCtD
Calcitriol—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00346	0.00459	CcSEcCtD
Calcitriol—Urinary tract infection—Mitoxantrone—lymphatic system cancer	0.00344	0.00457	CcSEcCtD
Calcitriol—Conjunctivitis—Mitoxantrone—lymphatic system cancer	0.00344	0.00457	CcSEcCtD
Calcitriol—Haemoglobin—Carmustine—lymphatic system cancer	0.00344	0.00457	CcSEcCtD
Calcitriol—Urticaria—Teniposide—lymphatic system cancer	0.00343	0.00456	CcSEcCtD
Calcitriol—Haemorrhage—Carmustine—lymphatic system cancer	0.00342	0.00454	CcSEcCtD
Calcitriol—Abdominal pain—Teniposide—lymphatic system cancer	0.00341	0.00454	CcSEcCtD
Calcitriol—Body temperature increased—Teniposide—lymphatic system cancer	0.00341	0.00454	CcSEcCtD
Calcitriol—Erythema—Bleomycin—lymphatic system cancer	0.00341	0.00453	CcSEcCtD
Calcitriol—Decreased appetite—Fludarabine—lymphatic system cancer	0.0033	0.00438	CcSEcCtD
Calcitriol—Constipation—Fludarabine—lymphatic system cancer	0.00325	0.00431	CcSEcCtD
Calcitriol—Pain—Fludarabine—lymphatic system cancer	0.00325	0.00431	CcSEcCtD
Calcitriol—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.0032	0.00424	CcSEcCtD
Calcitriol—Hypersensitivity—Teniposide—lymphatic system cancer	0.00318	0.00423	CcSEcCtD
Calcitriol—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.00318	0.00422	CcSEcCtD
Calcitriol—Asthenia—Teniposide—lymphatic system cancer	0.0031	0.00412	CcSEcCtD
Calcitriol—Pruritus—Teniposide—lymphatic system cancer	0.00306	0.00406	CcSEcCtD
Calcitriol—Arrhythmia—Carmustine—lymphatic system cancer	0.00306	0.00406	CcSEcCtD
Calcitriol—Body temperature increased—Fludarabine—lymphatic system cancer	0.003	0.00399	CcSEcCtD
Calcitriol—Erythema—Carmustine—lymphatic system cancer	0.00298	0.00395	CcSEcCtD
Calcitriol—Diarrhoea—Teniposide—lymphatic system cancer	0.00296	0.00393	CcSEcCtD
Calcitriol—Chest pain—Bleomycin—lymphatic system cancer	0.0029	0.00386	CcSEcCtD
Calcitriol—Myalgia—Bleomycin—lymphatic system cancer	0.0029	0.00386	CcSEcCtD
Calcitriol—Discomfort—Bleomycin—lymphatic system cancer	0.00287	0.00381	CcSEcCtD
Calcitriol—Urine output increased—Methotrexate—lymphatic system cancer	0.00285	0.00379	CcSEcCtD
Calcitriol—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00284	0.00377	CcSEcCtD
Calcitriol—Hypersensitivity—Fludarabine—lymphatic system cancer	0.0028	0.00372	CcSEcCtD
Calcitriol—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00278	0.0037	CcSEcCtD
Calcitriol—Erythema—Mitoxantrone—lymphatic system cancer	0.00277	0.00368	CcSEcCtD
Calcitriol—Vomiting—Teniposide—lymphatic system cancer	0.00275	0.00365	CcSEcCtD
Calcitriol—Agitation—Carmustine—lymphatic system cancer	0.00274	0.00363	CcSEcCtD
Calcitriol—Asthenia—Fludarabine—lymphatic system cancer	0.00272	0.00362	CcSEcCtD
Calcitriol—Rash—Teniposide—lymphatic system cancer	0.00272	0.00362	CcSEcCtD
Calcitriol—Dermatitis—Teniposide—lymphatic system cancer	0.00272	0.00361	CcSEcCtD
Calcitriol—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00271	0.0036	CcSEcCtD
Calcitriol—Headache—Teniposide—lymphatic system cancer	0.00271	0.00359	CcSEcCtD
Calcitriol—Pruritus—Fludarabine—lymphatic system cancer	0.00269	0.00357	CcSEcCtD
Calcitriol—Anorexia—Bleomycin—lymphatic system cancer	0.00265	0.00352	CcSEcCtD
Calcitriol—Agitation—Vincristine—lymphatic system cancer	0.00261	0.00347	CcSEcCtD
Calcitriol—Polyuria—Methotrexate—lymphatic system cancer	0.00261	0.00346	CcSEcCtD
Calcitriol—Diarrhoea—Fludarabine—lymphatic system cancer	0.0026	0.00345	CcSEcCtD
Calcitriol—Convulsion—Carmustine—lymphatic system cancer	0.00258	0.00343	CcSEcCtD
Calcitriol—Hypertension—Carmustine—lymphatic system cancer	0.00257	0.00341	CcSEcCtD
Calcitriol—Nausea—Teniposide—lymphatic system cancer	0.00257	0.00341	CcSEcCtD
Calcitriol—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00254	0.00337	CcSEcCtD
Calcitriol—Chest pain—Carmustine—lymphatic system cancer	0.00253	0.00337	CcSEcCtD
Calcitriol—Myalgia—Carmustine—lymphatic system cancer	0.00253	0.00337	CcSEcCtD
Calcitriol—Anxiety—Carmustine—lymphatic system cancer	0.00253	0.00335	CcSEcCtD
Calcitriol—Convulsion—Vincristine—lymphatic system cancer	0.00246	0.00327	CcSEcCtD
Calcitriol—Hypertension—Vincristine—lymphatic system cancer	0.00245	0.00326	CcSEcCtD
Calcitriol—Decreased appetite—Bleomycin—lymphatic system cancer	0.00242	0.00321	CcSEcCtD
Calcitriol—Myalgia—Vincristine—lymphatic system cancer	0.00242	0.00321	CcSEcCtD
Calcitriol—Vomiting—Fludarabine—lymphatic system cancer	0.00241	0.00321	CcSEcCtD
Calcitriol—Convulsion—Mitoxantrone—lymphatic system cancer	0.0024	0.00319	CcSEcCtD
Calcitriol—Rash—Fludarabine—lymphatic system cancer	0.00239	0.00318	CcSEcCtD
Calcitriol—Dermatitis—Fludarabine—lymphatic system cancer	0.00239	0.00318	CcSEcCtD
Calcitriol—Hypertension—Mitoxantrone—lymphatic system cancer	0.00239	0.00317	CcSEcCtD
Calcitriol—Pain—Bleomycin—lymphatic system cancer	0.00238	0.00316	CcSEcCtD
Calcitriol—Headache—Fludarabine—lymphatic system cancer	0.00238	0.00316	CcSEcCtD
Calcitriol—Myalgia—Mitoxantrone—lymphatic system cancer	0.00236	0.00313	CcSEcCtD
Calcitriol—Chest pain—Mitoxantrone—lymphatic system cancer	0.00236	0.00313	CcSEcCtD
Calcitriol—Anxiety—Mitoxantrone—lymphatic system cancer	0.00235	0.00312	CcSEcCtD
Calcitriol—Discomfort—Mitoxantrone—lymphatic system cancer	0.00233	0.00309	CcSEcCtD
Calcitriol—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00232	0.00308	CcSEcCtD
Calcitriol—Anorexia—Carmustine—lymphatic system cancer	0.00232	0.00308	CcSEcCtD
Calcitriol—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00226	0.003	CcSEcCtD
Calcitriol—Nausea—Fludarabine—lymphatic system cancer	0.00226	0.003	CcSEcCtD
Calcitriol—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00221	0.00294	CcSEcCtD
Calcitriol—Urticaria—Bleomycin—lymphatic system cancer	0.00221	0.00294	CcSEcCtD
Calcitriol—Anorexia—Vincristine—lymphatic system cancer	0.00221	0.00294	CcSEcCtD
Calcitriol—Body temperature increased—Bleomycin—lymphatic system cancer	0.0022	0.00292	CcSEcCtD
Calcitriol—Insomnia—Carmustine—lymphatic system cancer	0.0022	0.00292	CcSEcCtD
Calcitriol—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00219	0.00291	CcSEcCtD
Calcitriol—Somnolence—Carmustine—lymphatic system cancer	0.00216	0.00287	CcSEcCtD
Calcitriol—Anorexia—Mitoxantrone—lymphatic system cancer	0.00215	0.00286	CcSEcCtD
Calcitriol—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00211	0.00281	CcSEcCtD
Calcitriol—Decreased appetite—Carmustine—lymphatic system cancer	0.00211	0.00281	CcSEcCtD
Calcitriol—Insomnia—Vincristine—lymphatic system cancer	0.0021	0.00279	CcSEcCtD
Calcitriol—Pain—Carmustine—lymphatic system cancer	0.00208	0.00276	CcSEcCtD
Calcitriol—Constipation—Carmustine—lymphatic system cancer	0.00208	0.00276	CcSEcCtD
Calcitriol—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00206	0.00273	CcSEcCtD
Calcitriol—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00205	0.00272	CcSEcCtD
Calcitriol—Decreased appetite—Vincristine—lymphatic system cancer	0.00202	0.00268	CcSEcCtD
Calcitriol—Somnolence—Mitoxantrone—lymphatic system cancer	0.00201	0.00267	CcSEcCtD
Calcitriol—Asthenia—Bleomycin—lymphatic system cancer	0.002	0.00265	CcSEcCtD
Calcitriol—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00199	0.00264	CcSEcCtD
Calcitriol—Pain—Vincristine—lymphatic system cancer	0.00198	0.00263	CcSEcCtD
Calcitriol—Constipation—Vincristine—lymphatic system cancer	0.00198	0.00263	CcSEcCtD
Calcitriol—Pruritus—Bleomycin—lymphatic system cancer	0.00197	0.00262	CcSEcCtD
Calcitriol—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00196	0.00261	CcSEcCtD
Calcitriol—Pancreatitis—Methotrexate—lymphatic system cancer	0.00194	0.00258	CcSEcCtD
Calcitriol—Constipation—Mitoxantrone—lymphatic system cancer	0.00193	0.00257	CcSEcCtD
Calcitriol—Pain—Mitoxantrone—lymphatic system cancer	0.00193	0.00257	CcSEcCtD
Calcitriol—Abdominal pain—Carmustine—lymphatic system cancer	0.00192	0.00255	CcSEcCtD
Calcitriol—Body temperature increased—Carmustine—lymphatic system cancer	0.00192	0.00255	CcSEcCtD
Calcitriol—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.0019	0.00252	CcSEcCtD
Calcitriol—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00185	0.00245	CcSEcCtD
Calcitriol—Body temperature increased—Vincristine—lymphatic system cancer	0.00183	0.00244	CcSEcCtD
Calcitriol—Abdominal pain—Vincristine—lymphatic system cancer	0.00183	0.00244	CcSEcCtD
Calcitriol—Urticaria—Mitoxantrone—lymphatic system cancer	0.00179	0.00238	CcSEcCtD
Calcitriol—Hypersensitivity—Carmustine—lymphatic system cancer	0.00179	0.00238	CcSEcCtD
Calcitriol—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00179	0.00237	CcSEcCtD
Calcitriol—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00179	0.00237	CcSEcCtD
Calcitriol—Vomiting—Bleomycin—lymphatic system cancer	0.00177	0.00235	CcSEcCtD
Calcitriol—Drowsiness—Methotrexate—lymphatic system cancer	0.00176	0.00234	CcSEcCtD
Calcitriol—Rash—Bleomycin—lymphatic system cancer	0.00176	0.00233	CcSEcCtD
Calcitriol—Dermatitis—Bleomycin—lymphatic system cancer	0.00175	0.00233	CcSEcCtD
Calcitriol—Asthenia—Carmustine—lymphatic system cancer	0.00174	0.00232	CcSEcCtD
Calcitriol—Conjunctivitis—Methotrexate—lymphatic system cancer	0.00172	0.00228	CcSEcCtD
Calcitriol—Hypersensitivity—Vincristine—lymphatic system cancer	0.00171	0.00227	CcSEcCtD
Calcitriol—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00166	0.00221	CcSEcCtD
Calcitriol—Asthenia—Vincristine—lymphatic system cancer	0.00166	0.00221	CcSEcCtD
Calcitriol—Diarrhoea—Carmustine—lymphatic system cancer	0.00166	0.00221	CcSEcCtD
Calcitriol—Nausea—Bleomycin—lymphatic system cancer	0.00165	0.0022	CcSEcCtD
Calcitriol—Asthenia—Mitoxantrone—lymphatic system cancer	0.00162	0.00215	CcSEcCtD
Calcitriol—Haemoglobin—Methotrexate—lymphatic system cancer	0.00159	0.00211	CcSEcCtD
Calcitriol—Diarrhoea—Vincristine—lymphatic system cancer	0.00159	0.00211	CcSEcCtD
Calcitriol—Haemorrhage—Methotrexate—lymphatic system cancer	0.00158	0.0021	CcSEcCtD
Calcitriol—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00155	0.00205	CcSEcCtD
Calcitriol—Vomiting—Carmustine—lymphatic system cancer	0.00154	0.00205	CcSEcCtD
Calcitriol—Rash—Carmustine—lymphatic system cancer	0.00153	0.00203	CcSEcCtD
Calcitriol—Dermatitis—Carmustine—lymphatic system cancer	0.00153	0.00203	CcSEcCtD
Calcitriol—Headache—Carmustine—lymphatic system cancer	0.00152	0.00202	CcSEcCtD
Calcitriol—Erythema multiforme—Methotrexate—lymphatic system cancer	0.0015	0.00199	CcSEcCtD
Calcitriol—Vomiting—Vincristine—lymphatic system cancer	0.00147	0.00196	CcSEcCtD
Calcitriol—Rash—Vincristine—lymphatic system cancer	0.00146	0.00194	CcSEcCtD
Calcitriol—Dermatitis—Vincristine—lymphatic system cancer	0.00146	0.00194	CcSEcCtD
Calcitriol—Headache—Vincristine—lymphatic system cancer	0.00145	0.00193	CcSEcCtD
Calcitriol—Nausea—Carmustine—lymphatic system cancer	0.00144	0.00192	CcSEcCtD
Calcitriol—Vomiting—Mitoxantrone—lymphatic system cancer	0.00144	0.00191	CcSEcCtD
Calcitriol—Rash—Mitoxantrone—lymphatic system cancer	0.00142	0.00189	CcSEcCtD
Calcitriol—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00142	0.00189	CcSEcCtD
Calcitriol—Headache—Mitoxantrone—lymphatic system cancer	0.00142	0.00188	CcSEcCtD
Calcitriol—Erythema—Methotrexate—lymphatic system cancer	0.00138	0.00183	CcSEcCtD
Calcitriol—Nausea—Vincristine—lymphatic system cancer	0.00138	0.00183	CcSEcCtD
Calcitriol—Dysgeusia—Methotrexate—lymphatic system cancer	0.00135	0.00179	CcSEcCtD
Calcitriol—Nausea—Mitoxantrone—lymphatic system cancer	0.00134	0.00178	CcSEcCtD
Calcitriol—Convulsion—Methotrexate—lymphatic system cancer	0.00119	0.00159	CcSEcCtD
Calcitriol—Chest pain—Methotrexate—lymphatic system cancer	0.00117	0.00156	CcSEcCtD
Calcitriol—Myalgia—Methotrexate—lymphatic system cancer	0.00117	0.00156	CcSEcCtD
Calcitriol—Discomfort—Methotrexate—lymphatic system cancer	0.00116	0.00154	CcSEcCtD
Calcitriol—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.00113	0.00149	CcSEcCtD
Calcitriol—Skin disorder—Methotrexate—lymphatic system cancer	0.00109	0.00145	CcSEcCtD
Calcitriol—Anorexia—Methotrexate—lymphatic system cancer	0.00107	0.00142	CcSEcCtD
Calcitriol—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.00103	0.00136	CcSEcCtD
Calcitriol—Insomnia—Methotrexate—lymphatic system cancer	0.00102	0.00135	CcSEcCtD
Calcitriol—Somnolence—Methotrexate—lymphatic system cancer	0.001	0.00133	CcSEcCtD
Calcitriol—Decreased appetite—Methotrexate—lymphatic system cancer	0.000978	0.0013	CcSEcCtD
Calcitriol—Pain—Methotrexate—lymphatic system cancer	0.000962	0.00128	CcSEcCtD
Calcitriol—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.00092	0.00122	CcSEcCtD
Calcitriol—Urticaria—Methotrexate—lymphatic system cancer	0.000894	0.00119	CcSEcCtD
Calcitriol—Abdominal pain—Methotrexate—lymphatic system cancer	0.00089	0.00118	CcSEcCtD
Calcitriol—Body temperature increased—Methotrexate—lymphatic system cancer	0.00089	0.00118	CcSEcCtD
Calcitriol—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000829	0.0011	CcSEcCtD
Calcitriol—Asthenia—Methotrexate—lymphatic system cancer	0.000808	0.00107	CcSEcCtD
Calcitriol—Pruritus—Methotrexate—lymphatic system cancer	0.000796	0.00106	CcSEcCtD
Calcitriol—Diarrhoea—Methotrexate—lymphatic system cancer	0.00077	0.00102	CcSEcCtD
Calcitriol—Vomiting—Methotrexate—lymphatic system cancer	0.000716	0.00095	CcSEcCtD
Calcitriol—Rash—Methotrexate—lymphatic system cancer	0.00071	0.000942	CcSEcCtD
Calcitriol—Dermatitis—Methotrexate—lymphatic system cancer	0.000709	0.000942	CcSEcCtD
Calcitriol—Headache—Methotrexate—lymphatic system cancer	0.000705	0.000936	CcSEcCtD
Calcitriol—Nausea—Methotrexate—lymphatic system cancer	0.000669	0.000888	CcSEcCtD
